当前蛋白身份:P29678 重新检索
本组结构的主要差异维度
构建体不同 组装状态不同 配体/离子不同 实验环境不同 结构质量指标不同

差异标签只比较当前检索结果;所有PDB和assembly原始记录仍分别保留。

相关结构差异明细

一行代表一个 PDB 条目中的一个 biological assembly;同一蛋白的多个单体会分别列出。

PDB 条目 Assembly / 聚集状态 构建体 突变与修饰 配体、离子与非聚合物 实验方法 实验环境 结构质量
2Y4I KSR2-MEK1 heterodimer 提交 2011-01-06 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 1–393(393 aa)
未记录 ATP ADENOSINE-5'-TRIPHOSPHATE × 2 MG MAGNESIUM ION × 2 CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 6.25;293 K;12% (W/V) PEG 3350, 0.2 M NA CITRATE, 10 MM PR ACETATE, BIS-TRIS PROPANE PH 6.25.
分辨率 3.46 Å R-free 0.293
5KKR KSR2:MEK1 Complex Bound to the Small Molecule APS-2-79 提交 2016-06-22 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 C 1–393(393 aa)
未记录 6U7 6,7-dimethoxy-~{N}-(2-methyl-4-phenoxy-phenyl)quinazolin-4-amine × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.25;293 K;12% PEG-3350 100mM Bis-Tris 200mM Sodium Citrate 10mM Magnesium Acetate
分辨率 3.51 Å R-free 0.287
5KKR KSR2:MEK1 Complex Bound to the Small Molecule APS-2-79 提交 2016-06-22 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 1–393(393 aa)
未记录 6U7 6,7-dimethoxy-~{N}-(2-methyl-4-phenoxy-phenyl)quinazolin-4-amine × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.25;293 K;12% PEG-3350 100mM Bis-Tris 200mM Sodium Citrate 10mM Magnesium Acetate
分辨率 3.51 Å R-free 0.287
7JUQ Crystal Structure of KSR2:MEK1 in complex with ADP 提交 2020-08-20 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 35–393(359 aa)
未记录 ADP ADENOSINE-5'-DIPHOSPHATE × 2 MG MAGNESIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;PEG 2000, MES, pH 6.5, Magnesium acetate
分辨率 3.22 Å R-free 0.288
7JUR Crystal Structure of KSR2:MEK1 in complex with AMP-PNP, and allosteric MEK inhibitor Trametinib 提交 2020-08-20 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 35–393(359 aa)
未记录 ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 2 MG MAGNESIUM ION × 2 QOM Trametinib × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;12% PEG-3350, 100 mM MES pH 6.25, 200 mM Magnesium Acetate
分辨率 2.82 Å R-free 0.277
7JUS Crystal Structure of KSR2:MEK1 in complex with AMP-PNP, and allosteric MEK inhibitor Cobimetinib 提交 2020-08-20 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 35–393(359 aa)
未记录 ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 2 MG MAGNESIUM ION × 2 VKD Cobimetinib × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;PEG 2000, MES, pH 6.5, Magnesium acetate
分辨率 2.99 Å R-free 0.265
7JUT Crystal Structure of KSR2:MEK1 in complex with ANP-PNP, and allosteric MEK inhibitor Selumetinib 提交 2020-08-20 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 35–393(359 aa)
未记录 ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 2 3EW 5-[(4-bromo-2-chlorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;PEG 2000, MES, pH 6.5, Magnesium acetate
分辨率 3.09 Å R-free 0.300
7JUU Crystal Structure of KSR2:MEK1 in complex with AMP-PNP, and allosteric MEK inhibitor PD0325901 提交 2020-08-20 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 35–393(359 aa)
未记录 ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 2 MG MAGNESIUM ION × 2 4BM N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;PEG 2000, MES, pH 6.5, Magnesium acetate
分辨率 3.19 Å R-free 0.258
7JUV Crystal Structure of KSR2:MEK1 in complex with AMP-PNP, and allosteric MEK inhibitor APS-9-95-1 提交 2020-08-20 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 35–393(359 aa)
未记录 ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 2 MG MAGNESIUM ION × 2 VKG N-(3-{3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl}phenyl)-N'-methylsulfuric diamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;PEG 2000, MES, pH 6.5, Magnesium acetate
分辨率 3.36 Å R-free 0.255
7JUW Crystal Structure of KSR1:MEK1 in complex with AMP-PNP 提交 2020-08-20 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:trimeric(3) 待复核
链 C 35–393(359 aa)
未记录 ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 2 MG MAGNESIUM ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;PEG 2000, MES pH 6.5, Magnesium Acetate
分辨率 2.88 Å R-free 0.286
7JUX Crystal Structure of KSR1:MEK1 in complex with AMP-PNP, and allosteric MEK inhibitor Trametinib 提交 2020-08-20 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:trimeric(3) 待复核
链 C 35–393(359 aa)
未记录 ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 2 MG MAGNESIUM ION × 1 QOM Trametinib × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;PEG 2000, MES, pH 6.5, Magnesium acetate
分辨率 3.34 Å R-free 0.283
7JUY Crystal Structure of KSR1:MEK1 in complex with AMP-PNP, and allosteric MEK inhibitor Cobimetinib 提交 2020-08-20 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:trimeric(3) 待复核
链 C 35–393(359 aa)
未记录 ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 2 MG MAGNESIUM ION × 2 EUI [3,4-BIS(FLUORANYL)-2-[(2-FLUORANYL-4-IODANYL-PHENYL)AMINO]PHENYL]-[3-OXIDANYL-3-[(2S)-PIPERIDIN-2-YL]AZETIDIN-1-YL]METHANONE × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;PEG 2000, MES, pH 6.5, Magnesium acetate
分辨率 3.10 Å R-free 0.257
7JUZ Crystal Structure of KSR1:MEK1 in complex with AMP-PNP, and allosteric MEK inhibitor Selumetinib 提交 2020-08-20 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:trimeric(3) 待复核
链 C 35–393(359 aa)
未记录 ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 2 3EW 5-[(4-bromo-2-chlorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;PEG 2000, MES, pH 6.5, Magnesium acetate
分辨率 3.21 Å R-free 0.272
7JV0 Crystal Structure of KSR1:MEK1 in complex with AMP-PNP, and allosteric MEK inhibitor PD0325901 提交 2020-08-20 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:trimeric(3) 待复核
链 C 35–393(359 aa)
未记录 ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 2 MG MAGNESIUM ION × 1 4BM N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;PEG 2000, MES, pH 6.5, Magnesium acetate
分辨率 3.63 Å R-free 0.260
7JV1 Crystal Structure of KSR1:MEK1 in complex with AMP-PNP, and allosteric MEK inhibitor APS-9-95-1 提交 2020-08-20 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:trimeric(3) 待复核
链 C 35–393(359 aa)
未记录 ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 2 MG MAGNESIUM ION × 1 VKG N-(3-{3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl}phenyl)-N'-methylsulfuric diamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;PEG 2000, MES, pH 6.5, Magnesium acetate
分辨率 3.62 Å R-free 0.303